Calling 2

Calling

Calling 3Roman Crazzolara takes over the first professor of pediatric oncology at the University of Innsbruck.

On Wednesday, a presentation of the first Pediatric Oncology Teacher at the Innsbruck Medical School was held at Innsbruck's Children's Hospital. A dedicated professor was created in cooperation with Kinder-Krebs-Hilfe Tirol and Vorarlberg. Professor Roman Crazzolara (45) presented the focus of his teaching and research concept.

The mission of the endorsed profession is the sustainable strengthening of pediatric oncology in science, education and health in Innsbruck. Recent research results are aimed directly at children and adolescents who are suffering from cancer in terms of the best possible ways to improve their quality of life and treatment. A well-versed professor for deep research on childhood oncology was provided with the financial support of Kinder-Krebs-Hilfe for Tirol and Vorarlberg in the amount of 500,000 euros.

"It is truly unbelievable that as a volunteer club we can co-fund this dedicated profession with 500,000 euros, so I sincerely thank our members and donors for their donations will continue to improve the treatment and treatment of cancer-, explains Ursula Mattersberger, vice president of child aid for cancer in Austria and Obfrau for Tyrol and Vorarlberg.

An expert knows a qualified professor

Along with the original South-Tyrolean novel Crazzolor, an internationally renowned pediatric oncology expert has been named a full professor. The father of three children after the research remains u.a. at the Millennium Institute at the University of Sydney, since 2009 on pediatric hematology, oncology and transplantation of stem cells of the University Hospital Innsbruck.

"With Romanom Crazzolara, we have appointed a dedicated and award-winning pediatric specialist who specializes in hematology and oncology. Among other things, he will set new trends in research and thus make an important contribution to improving treatment for cancer patients.", explains Christine Bandtlow, Vice Rector for Research and International Cooperation. "It is of great importance to the association and to all the donors who, together with their support, have made it possible to create this profession, and I would like to thank them, which will enable us to sustainably strengthen pediatric oncology in science, education and healthcare.

Calling 4Alexandra Kofler, Medical Director Landeskrankenhaus Innsbruck, thanks Kinder-Krebs-Hilfe Tirol and Vorarlberg for their unique funding and is very pleased with the appointment: "Thanks to the financial support for Cancer Care, it is possible to link a pediatric oncologist with Roman Crazzolar to the field, not only professionally but also humanly, at least as important in this area, so Kofler.

The foundation of the Department of Pediatric Oncology was also fulfilled by the heartwalk of Thomas Müller, Director of the Children's Clinic Innsbruck: "When I was at the clinic two years ago, the onus of childhood oncology was a top priority. Childrens Cancer help Tyrol and Vorarlberg and their generous donors and the Innsbruck Medical University in the short term have fulfilled this desire for the heart in the sense that our children are suffering from cancer. For that I am endlessly gratefulsays Müller.

Four focal points of the Professor of Pediatric Oncology

The subject of the professed profession was applied research and supervision of the so-called. Survivors (children and adolescents with cancer therapy). Special emphasis will be placed on areas of "patient-oriented medicine", "secondary and tertiary prevention and after-care" and "support for new therapies" and "visibility of teaching and research activities". "I look forward to the personal opportunity for further development of the extraordinary work of the children's hospital in Innsbruck and the continuation of thorough, deep research and teaching about the cancer of children expand "explains Crazzolara.

Patient-oriented medicine

Crazzolara explains that for successful therapy, apart from medical information on the clinical picture, it is also decisive as a child or adolescent feels. Knowledge of personal well-being and subjective parameters such as pain, fatigue, or social consequences of the disease are more important for assessing oncology therapies. Especially in the case of children and adolescents, it is sensible and necessary to review their own feelings of illness, apart from their parents.

Routine data collection (so-called Patient Outcomes, PRO) offers several advantages: identification of damage, improved communication between doctors and patients, more comprehensive assessment of the success of the treatment and direct coordination of interventions with individual needs. For this purpose, Patient Reported Outcome Measures (PROMs) and appropriate software solutions for the simple recording and verification of vital functions of small patients, not only in the hospital area, but also when the child is at home.

Extension of secondary and tertiary prevention and subsequent care

Within a secular profession, actual early detection (secondary prevention), prevention of re-occurrence or return (tertiary prevention) and treatment of long-term consequences must be expanded and deepened in terms of content. The transition of young people into adult medicine should also be a major factor.

Support for new clinical therapies

By conducting and participating in new therapy studies it is necessary to increase the knowledge about the long-term consequences of cancer in childhood and adolescence. "Findings help us to offer even better treatment, but more so that we can better cope with the difficulties during therapy."Crazzolara said. New drugs, medicines and therapies will be used for the benefit of sick children and adolescents to raise the international peak of survival from 5 years now to over 80 percent. After the EUROCARE 5 study, Austria leads.

Increased public visibility of teaching and research

Another central point for Crazzolare is the increase in public relations in order to raise public awareness of cancer in children and adolescents. Also, results of research at the Medical School and Tyrolean clinics are regularly published.

A dedicated professor offers opportunities for better therapy

The Professorship for Pediatric Oncology enables cancer patients and cancer patients with new opportunities for even better therapy. It started in June 2019 and is limited to five years with two scientific assistants.

Photo (s): © 123RF.com and / or © Arhiva Neue Südtiroler Tageszeitung GmbH (if no indication)